Some cytokines, including IL-3, IL-6, and IL-16, ended up being upregulated in prostate cancer patients and others, including Fas/TNFRSF6, TRALR-3, and IGFBP-6, markedly downregulated [74]. This evidence concerns the gene FAS and prostate cancer.